Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Arch Therapeutics Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
ARTH
Over the counter
3841
https://www.archtherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Arch Therapeutics Inc
Arch Therapeutics Provides Update on Reimbursement Strategy in Additional Selling Channel
- Jun 22nd, 2022 11:50 am
Arch Therapeutics’ Experts in Wound Care Interview Showcases AC5 Self-Assembling Peptide Technology During Live Session at SAWC Spring
- May 9th, 2022 11:50 am
Renowned Wound Care Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Spring
- Apr 13th, 2022 11:50 am
Arch Therapeutics’ AC5® Advanced Wound System to be Presented at 2022 Symposium on Advanced Wound Care (SAWC) Spring
- Apr 4th, 2022 11:50 am
Arch Therapeutics Partners with Centurion Therapeutics to Expand Access to AC5® Advanced Wound System
- Mar 14th, 2022 11:50 am
Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds in Patients with Previously Unsuccessful Treatments and Significant Comorbidities
- Jan 6th, 2022 12:50 pm
Arch Therapeutics Announces Appointment of Guy Fish to the Board
- Jan 4th, 2022 2:47 pm
Arch Therapeutics Granted Federal Supply Schedule and General Supply Administration Contracts for AC5® Advanced Wound System
- Dec 13th, 2021 12:50 pm
Arch Therapeutics Adds Key Opinion Leader Interview on Diabetic Foot Ulcers to the Experts in Wound Care Program
- Dec 1st, 2021 12:50 pm
Arch Therapeutics Presents AC5® Advanced Wound System During Innovation Spotlight at 2021 Symposium on Advanced Wound Care (SAWC)
- Nov 1st, 2021 11:50 am
Arch Therapeutics to Present AC5 Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC) Fall
- Oct 25th, 2021 11:50 am
Arch Therapeutics Launches Experts in Wound Care Program
- Oct 18th, 2021 11:50 am
Arch Therapeutics Provides Corporate Update
- Oct 13th, 2021 8:30 pm
Arch Therapeutics to Present at the LD Micro Main Event
- Oct 6th, 2021 11:50 am
Arch Therapeutics Launches Coverage and Reimbursement Pilot
- Oct 4th, 2021 11:50 am
Arch Therapeutics Announces Appointment of Larry Hicks to the Board
- Sep 30th, 2021 11:50 am
Arch Therapeutics Partners with Lovell Government Services to Expand Distribution Capabilities
- Sep 2nd, 2021 11:00 am
Arch Therapeutics Completes Leadership Team with Appointment of Dan Yrigoyen as Vice President of Sales
- Jul 12th, 2021 11:50 am
Arch Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference, July 13 - 14, 2021
- Jul 7th, 2021 11:50 am
Scroll